USPTO serial 87230672
BLÜM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BLÜM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan A. Hyman
Jonathan A. Hyman KNOBBE MARTENS OLSON & BEAR LLP2040 MAIN STREET, 14TH FLOORIrvine, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Goods permitted by the Farm Bill and not subject to the FDCA: Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves all of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Non-mediated topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves all of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Dietary and nutritional supplements containing CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Medicated edible products containing CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated oils containing CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Medicated confectionary comprised of CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Herbal hemp oil for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Pharmaceutical preparations, namely, herbal sprays and oils containing CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis in whole or significant part for relief of aches, pains, and anxiety; Medicated topical creams, salves, lotions, and balms for use on skin to relieve aches or pains, all of the foregoing made from CBD derived from legal industrial hemp containing less than 0.3% tetrahydrocannabinol on a dry weight basis; medicated topical creams, salves, lotions, and balms for use on skin, all of the foregoing made from CBD derived from legal industrial hemp containing less than 0.3% tetrahydrocannabinol on a dry weight basis; Non-medicated topical creams, salves, lotions, and balms for use on skin, all of the foregoing containing cannabidiol (CBD) derived from industrial hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Skin creams, skin lotions, and body oils, all of the foregoing containing cannabidiol (CBD) solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Face and body creams containing cannabidiol (CBD) solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Non-medicated herbal body care products, namely, salves and lip balms containing cannabidiol (CBD) solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Skin creams in solid form, all of the foregoing containing cannabidiol (CBD) solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, Dietary and nutritional supplements, Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods, Medicated oils, Medicated confectionary, and Pharmaceutical preparations, namely, herbal sprays and oils in whole or significant part for relief of aches, pains, and anxiety all of the aforementioned goods with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Goods that do not contain any reference to cannabis, hemp, industrial hemp, CBD, or cannabidiol oil: Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Dietary and nutritional supplements none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated oils, Medicated confectionary, and Pharmaceutical preparations, namely, herbal sprays and oils in whole or significant part for relief of aches, pains, and anxiety, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Goods not subject to CSA or FDCA: Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing CBD derived from industrial hemp; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing industrial hemp; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing sterilized hemp seeds, mature stalk and containing no other cannabis ingredients; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing CBD that contains no more than 0.3 % THC on a dry weight basis; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing industrial hemp; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hemp; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hemp extracts; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hemp extracts, namely, industrial hemp-derived cannabidiol (CBD); Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hemp extracts, namely, industrial hemp-derived cannabidiol oil; Dietary and nutritional supplements containing CBD derived from industrial hemp; Dietary and nutritional supplements containing industrial hemp; Dietary and nutritional supplements containing sterilized hemp seeds, mature stalk and containing no other cannabis ingredients; Dietary and nutritional supplements containing hulled hemp seeds, hemp seed protein and hemp seed oil; Dietary and nutritional supplements containing CBD that contains no more than 0.3 % THC on a dry weight basis; Dietary and nutritional supplements containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds; Dietary and nutritional supplements containing industrial hemp; Dietary and nutritional supplements containing hemp; Dietary and nutritional supplements not containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Dietary and nutritional supplements containing hemp extracts; Dietary and nutritional supplements containing hemp extracts, namely, industrial hemp-derived cannabidiol (CBD); Dietary and nutritional supplements containing hemp extracts, namely, industrial hemp-derived cannabidiol oil; Medicated edible products containing CBD derived from industrial hemp, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing industrial hemp, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing sterilized hemp seeds, mature stalk and containing no other cannabis ingredients, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing hulled hemp seeds, hemp seed protein and hemp seed oil, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing CBD that contains no more than 0.3 % THC on a dry weight basis, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing industrial hemp, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing hemp, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products not containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing hemp extracts, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing hemp extracts, namely, industrial hemp-derived cannabidiol (CBD) , namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated edible products containing hemp extracts, namely, industrial hemp-derived cannabidiol oil, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated oils containing CBD derived from industrial hemp; Medicated oils containing industrial hemp; Medicated oils containing sterilized hemp seeds, mature stalk and containing no other cannabis ingredients; Medicated oils containing hulled hemp seeds, hemp seed protein and hemp seed oil; Medicated oils containing CBD that contains no more than 0.3 % THC on a dry weight basis; Medicated oils containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds; Medicated oils containing industrial hemp; Medicated oils containing hemp; Medicated oils not containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated oils containing hemp extracts; Medicated oils containing hemp extracts, namely, industrial hemp-derived cannabidiol (CBD); Medicated oils containing hemp extracts, namely, industrial hemp-derived cannabidiol oil; Medicated confectionary comprised of CBD derived from industrial hemp; Medicated confectionary comprised of industrial hemp; Medicated confectionary comprised of sterilized hemp seeds, mature stalk and containing no other cannabis ingredients; Medicated confectionary comprised of hulled hemp seeds, hemp seed protein and hemp seed oil; Medicated confectionary comprised of CBD that contains no more than 0.3 % THC on a dry weight basis; Medicated confectionary comprised of CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds; Medicated confectionary comprised of industrial hemp; Medicated confectionary comprised of hemp; Medicated confectionary not containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated confectionary comprised of hemp extracts; Medicated confectionary comprised of hemp extracts, namely, industrial hemp-derived cannabidiol (CBD); Medicated confectionary comprised of hemp extracts, namely, industrial hemp-derived cannabidiol oil; Pharmaceutical preparations, namely, herbal sprays and oils containing cannabidiol (CBD) derived from industrial hemp in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing CBD derived from industrial hemp in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing industrial hemp in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing sterilized hemp seeds, mature stalk and containing no other cannabis ingredients in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing hulled hemp seeds, hemp seed protein and hemp seed oil in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing CBD that contains no more than 0.3 % THC on a dry weight basis in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing industrial hemp in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing hemp in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils not containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing hemp extracts in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing hemp extracts, namely, industrial hemp-derived cannabidiol (CBD) in whole or significant part for relief of aches, pains, and anxiety; Pharmaceutical preparations, namely, herbal sprays and oils containing hemp extracts, namely, industrial hemp-derived cannabidiol oil in whole or significant part for relief of aches, pains, and anxiety; Herbal hemp oil for therapeutic and medical purposes; herbal hemp seed oil for therapeutic and medical purposes; Goods potentially subject to CSA and the FDCA: Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing CBD; Dietary and nutritional supplements containing CBD; Medicated edible products containing CBD, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed based snack foods, and grain based snack foods; Medicated oils containing CBD; Medicated confectionary comprised of CBD; Pharmaceutical preparations, namely, herbal sprays and oils containing CBD in whole or significant part for relief of aches, pains, and anxiety | ACTIVE | — |
| 034 | Goods permitted by the Farm Bill: Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions derived from cannabis, hemp, industrial hemp, CBD, or cannabidiol oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit; Vaporizers for medical purposes containing CBD derived from legal industrial hemp containing less than 0.3% tetrahydrocannabinol on a dry weight basis; atomizers sold empty for medical use; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the aforementioned goods with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing CBD that contains no more than 0.3% THC on a dry weight basis and exclusively for use with CBD that contains no more than 0.3% THC on a dry weight basis; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds and exclusively for use with CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds; Goods that do not contain any reference to cannabis, hemp, industrial hemp, CBD, or cannabidiol oil: Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions derived from industrial hemp being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil that do not contain any other cannabis or hemp products, and that the cartomizers and atomizers are not intended for use with any other cannabis or hemp products; Goods not subject to CSA: Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions containing CBD derived from industrial hemp being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions containing industrial hemp being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing sterilized hemp seeds, mature stalk and containing no other cannabis ingredients; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing CBD that contains no more than 0.3 % THC on a dry weight basis; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing industrial hemp; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit all of the foregoing containing hemp; and Goods potentially subject to CSA: Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty and atomizers and refill liquid solutions containing CBD being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 18, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 18, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 19, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 3, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 3, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 3, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 22, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | IIOA | INADVERTENTLY ISSUED OFFICE ACTION | — |
| Feb 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Dec 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 5, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 5, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2019 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 3, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 27, 2017 | ALIE | ASSIGNED TO LIE | — |
| Nov 14, 2017 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Nov 13, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2017 | PETG | PETITION TO REVIVE-GRANTED | — |
| Nov 13, 2017 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Sep 22, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 22, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 15, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 15, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 24, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 11, 2016 | NWAP | NEW APPLICATION ENTERED | — |